Modeling intracranial second tumor risk and estimates of clinical toxicity with various radiation therapy techniques for patients with pituitary adenoma

Technology in Cancer Research and Treatment

Volumn 10, Issue 3, 2011, Pages 243-251

  Winkfield, K M ^a   Niemierko, A ^a   Bussiere M R ^a   Crowley, E M ^a   Napolitano, B N ^a   Beaudette, K P ^a   Loeffler, J S ^a   Shih, H A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Conformal radiation therapy; Pituitary adenoma; Proton radiation therapy; Radiation toxicity; Second tumor risk

Indexed keywords

ARTICLE; CANCER RISK; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; HISTOGRAM; HUMAN; HYPOPHYSIS ADENOMA; INTENSITY MODULATED RADIATION THERAPY; INTRACRANIAL TUMOR; MAJOR CLINICAL STUDY; PHOTON THERAPY; RADIATION INDUCED NEOPLASM; STEREOTACTIC BODY RADIATION THERAPY; TEMPORAL LOBE;

EID: 79955547394     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500199     Document Type: Article

References (36)

1. Neglia, J., Robison, L., Stovall, M., Liu, Y., Packer, R., Hammond, S., Yasui, Y., Kasper, C., Mertens, A., Donaldson, S., Meadows, A., Inskip, P. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98, 1528-1537 (2006).
2. Neglia, J., Meadows, A., Robison, L., Kim, T., Newton, W., Ruymann, F., Sather, H., Hammond, G. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 325, 1330-1336 (1991).
3. Sadetzki, S., Flint-Richter, P., Ben-Tal, T., Nass D. Radiation-induced meningioma: a descriptive study of 253 cases. J Neurosurg 97, 1078-1082 (2002).
4. Minniti, G., Traish, D., Ashley, S., Gonsalves, A., Brada, M. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab 90, 800-804 (2005).
5. Blettner, M., Boice, J., Jr. Radiation dose and leukaemia risk: general relative risk techniques for dose-response models in a matched case-control study. Stat Med 10, 1511-1526 (1991).
6. Dorr, W., Herrmann, T. Second primary tumors after radiotherapy for malignancies. Treatment-related parameters. Strahlenther Onkol 178, 357-362 (2002).
7. Hall, E. J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65, 1-7 (2006).
8. Hermanto, U., Frija, E., Lii, M., Chang, E., Mahajan, A., Woo, S. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys 67, 1135-1144 (2007).
9. Schneider, U., Lomax, A., Lombriser, N. Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin's disease with photon and proton radiation. Radiat Res 154, 382-388 (2000).
10. Takam, R., Bezak, E., Yeoh, E. Risk of second primary cancer following prostate cancer radiotherapy: DVH analysis using the competitive risk model. Phys Med Biol 54, 611-625 (2009).
11. Zwahlen, D., Martin, J., Millar, J., Schneider, U. Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma. Int J Radiat Oncol Biol Phys 70, 853-858 (2008).
12. Bortfeld, T. IMRT: a review and preview. Phys Med Biol 51, R363-379 (2006).
13. Dasu, A., Toma-Dasu, I., Olofsson, J., Karlsson, M. The use of risk estimation models for the induction of secondary cancers following radiotherapy. Acta Oncol 44, 339-347 (2005).
14. Animesh. Advantages of multiple algorithm support in treatment planning system for external beam dose calculations. J Cancer Res Ther 1, 12-20 (2005).
15. Schneider, U., Zwahlen, D., Ross, D., Kaser-Hotz, B. Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose. Int J Radiat Oncol Biol Phys 61, 1510-1515 (2005).
16. UNSCEAR. http://www.unscear.org/reports/2000_2.html (2000).
17. Niemierko, A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys 24, 103-110 (1997).
18. Wu, Q., Mohan, R., Niemierko, A., Schmidt-Ullrich, R. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 52, 224-235 (2002).
19. Niemierko, A., Pommier, P., Adams, J., Fullerton, B., Lopes, V., Moulton, G., Thornton, A., Loeffler, J., Chan, A. Dose-Volume Characteristics of Brain Lobe Late Response Following Proton-Photon Radiotherapy of Paranasal Sinus Cancer. Int J Radiat Oncol Biol Phys 63, S267 (2005).
20. Pommier, P., Niemierko, A., Adams, J., Thornton, A., Loeffler, J., Chan, A. Equivalent uniform dose predicts delayed hyperintensity on T1-weighted magnetic resonance imaging after combined proton and photon irradiation in paranasal sinus cancer. Int J Radiat Oncol Biol Phys 60, S501-S502 (2004).
21. Aoyama, H., Westerly, D., Mackie, T., Olivera, G., Bentzen, S., Patel, R., Jaradat, H., Tome, W., Ritter, M., Mehta, M. Integral radiation dose to normal structures with conformal external beam radiation. Int J Radiat Oncol Biol Phys 64, 962-967 (2006).
22. Karlsson, P., Holmberg, E., Samuelsson, A., Johansson, K., Wallgren, A. Soft tissue sarcoma after treatment for breast cancer--a Swedish population-based study. Eur J Cancer 34, 2068-2075 (1998).
23. Nguyen, F., Rubino, C., Guerin, S., Diallo, I., Samand, A., Hawkins, M., Oberlin, O., Lefkopoulos, D., De Vathaire, F. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields. Int J Radiat Oncol Biol Phys 70, 908-915 (2008).
24. Hall, E., Wuu, C. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56, 83-88 (2003).
25. Ruben, J., Davis, S., Evans, C., Jones, P., Gagliardi, F., Haynes, M., Hunter, A. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies. Int J Radiat Oncol Biol Phys 70, 1530-1536 (2008).
26. Levin, W., Kooy, H., Loeffler, J., DeLaney, T. Proton beam therapy. Br J Cancer 93, 849-854 (2005).
27. Merchant, T., Hua, C., Shukla, H. Ying, X., Nill, S., Oelfke, U. Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer 51, 110-117 (2008).
28. Taddei, P., Mirkovic, D., Fontenot, J., Giebeler, A., Zheng, Y., Kornguth, D., Mohan, R., Newhauser, W. Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beam. Phys Med Biol 54, 2259-2275 (2009).
29. Fontenot, J., Lee, A., Newhauser, W. Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer. Int J Radiat Oncol Biol Phys 74, 616-622 (2009).
30. Newhauser, W., Fontenot, J., Mahajan, A., Kornguth, D., Stovall, M., Zheng, Y., Taddei, P., Mirkovic, D., Mohan, R., Cox, J., Woo S. The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol 54, 2277-2291 (2009).
31. Crossen, J., Garwood, D., Glatstein, E., Neuwelt, E. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12, 627-642 (1994).
32. Laack, N., Brown, P. Cognitive sequelae of brain radiation in adults. Semin Oncol 31, 702-713 (2004).
33. Lindsay, K., Wheldon, E., Deehan, C., Wheldon, T. Radiation carcinogenesis modelling for risk of treatment-related second tumours following radiotherapy. Br J Radiol 74, 529-536 (2001).
34. Schneider, U., Kaser-Hotz, B. Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose-response relationships. Radiat Environ Biophys 44, 235-239 (2005).
35. Schneider, U., Kaser-Hotz, B. A simple dose-response relationship for modeling secondary cancer incidence after radiotherapy. Z Med Phys 15, 31-37 (2005).
36. Sachs, R., Brenner, D. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci U S A 102, 13040-13045 (2005).